Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
farmakokineetika oli ühesugune nii kõikides soliidtuumoritega populatsioonides kui ka tervetel vabatahtlikel.
the pharmacokinetics were similar in all solid tumour populations tested and in healthy volunteers.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
bevatsizumabi farmakokineetilised andmed on saadud kümnest kliinilisest uuringust soliidtuumoritega patsientidel.
the pharmacokinetic data for bevacizumab are available from ten clinical trials in patients with solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
analüüs põhines gisti või soliidtuumoritega täiskasvanutelt ning soliidtuumoritega lastelt kogutud andmetel.
this analysis was based on data collected from adults with gist or solid tumours, and from paediatric patients with solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
platseebokontrollitud qt/qtc uuringus trabektediin ei pikendanud qtc intervalli kaugelearenenud soliidtuumoritega patsientidel.
in a placebo-controlled qt/qtc study, trabectedin did not prolong the qtc interval in patients with advanced solid malignancies.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
gemzar mõjub eelkõige s- faasis rakkudele ja teda manustatakse soliidtuumoritega patsientide ravis.
it is primarily active against cells in the s phase and is given in the management of solid tumours.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
imatinib medac on retseptiravim ja ravi peab alustama üksnes verevähi või soliidtuumoritega patsientide ravis kogenud arst.
it can only be obtained with a prescription and treatment should be started by a doctor who has experience in the treatment of patients with cancers of the blood or solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lipaasi aktiivsuse suurenemine oli ajutine ja tavaliselt ei kaasnenud sellega pankreatiidinähtusid või sümptomeid nendel mitmesuguste soliidtuumoritega patsientidel.
increases in lipase activities were transient and were generally not accompanied by signs or symptoms of pancreatitis in subjects with various solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lenvatiniibi farmakokineetilisi parameetreid on uuritud tervetel täiskasvanud uuringus osalejatel ning maksakahjustusega, neerukahjustusega ja soliidtuumoritega uuringus osalejatel.
pharmacokinetic parameters of lenvatinib have been studied in healthy adult subjects, adult subjects with hepatic impairment, renal impairment, and solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
avaldatud uuringud näitasid, et tiotepa koos teiste keemiaravi ravimitega on verehaiguste ja soliidtuumoritega täiskasvanute ning laste ravis kasulik.
the published studies showed that thiotepa used in combination with other chemotherapy medicines is beneficial to adults and children being treated for blood diseases and solid tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
olemasolevad tõendid lubavad eeldada, et hematoloogiliste pahaloomuliste kasvajatega ja soliidtuumoritega patsiendid reageerivad alfaepoetiinravile võrdväärselt ning et luuüdi kasvajainfiltraadiga või kasvajainfiltraadita patsiendid reageerivad alfaepoetiinravile võrdväärselt.
available evidence suggests patients with haematological malignancies and solid tumours respond equivalently to epoetin alfa therapy, and that patients with or without tumour infiltration of the bone marrow respond equivalently to epoetin alfa therapy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alfaepoetiini on kliinilistes uuringutes uuritud aneemiat põdevatel lümfoidsete ja soliidtuumoritega täiskasvanud patsientidel ning erinevaid keemiaraviskeeme, sh plaatinat sisaldavad ja mittesisaldavad skeemid, saavatel patsientidel.
epoetin alfa has been studied in clinical trials in adult anaemic cancer patients with lymphoid and solid tumors, and patients on various chemotherapy regimens, including platinum and non-platinum- containing regimens.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
allpool on loetletud organsüsteemi klasside, esinemissageduste ja raskusastme kaupa raviga seotud kõrvaltoimed, millest teatas > 2% soliidtuumoritega patsientidest.
treatment-related adverse reactions that were reported in > 2% of solid tumour patients are listed below, by system organ class, frequency and grade of severity.
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
Warning: Contains invisible HTML formatting
kolmandas uuringus osales 1776 eri kehaosade (v.a rinnanääre või eesnääre) soliidtuumoritega või hulgimüeloomiga (luuüdi vähk) patsienti.
the third study involved 1,776 patients with advanced solid tumours in various parts of the body, excluding the breast or the prostate, or with multiple myeloma (a cancer of the bone marrow).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pärast abraxane’i manustamist soliidtuumoritega patsientidele jaotub paklitakseel ühtlaselt vererakkudesse ja -plasmasse ning seondub suurel määral vereplasma valkudega (94%).
following abraxane administration to patients with solid tumours, paclitaxel is evenly distributed into blood cells and plasma and is highly bound to plasma proteins (94%).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vectibix’ i uuriti täiendavalt monoteraapiana teiste soliidtuumoritega patsientidel ja kombinatsioonis kemoteraapiaga, kas koos bevatsizumabiga või ilma mkrk- i põdevatel patsientidel või kombinatsioonis kemoteraapiaga mitte- väikerakulise kopsuvähiga patsientidel.
additional studies were performed with vectibix as a single agent in patients with other solid tumours and in combination with chemotherapy with and without bevacizumab in patients with mcrc or in combination with chemotherapy in patients with non-small cell lung cancer.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
soliidtuumoritega patsientidel (sealhulgas rinnanäärme- ja munasarjavähiga patsientidel) läbi viidud kliinilistes uuringutes, milles samaaegselt caelyx’iga manustati tsüklofosfamiidi või taksaane, ei täheldatud aditiivset toksilisust.
during clinical trials in patients with solid tumours (including breast and ovarian cancer) who have received concomitant cyclophosphamide or taxanes, no new additive toxicities were noted.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: